Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex.
Saved in:
| Title: | Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex. |
|---|---|
| Authors: | Harlass M; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Knudsen AB; Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, United States.; Department of Radiology, Harvard Medical School, Boston, MA, United States., Nieboer D; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., van Duuren LA; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Kuntz KM; Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, United States., Rutter CM; Biostatistics Program, Public Health Sciences Division, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, United States., Nascimento de Lima P; Engineering and Applied Sciences Department, RAND Corporation, Arlington VA, United States., Collier N; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States., Ozik J; Decision and Infrastructure Sciences, Argonne National Laboratory, Lemont, IL, United States.; Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, United States., Hahn AI; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Alarid-Escudero F; Department of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.; Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, United States., Zauber AG; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Inadomi JM; Department of Internal Medicine, The Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, United States., Meester RGS; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.; Health Economics and Outcomes Research, Freenome Holdings Inc, South San Francisco, CA, United States.; Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Stanford, CA, United States., Lansdorp-Vogelaar I; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Nov 01; Vol. 117 (11), pp. 2219-2228. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
